Table 3.
Relative importance of clinical outcomes: results from Migraine Relief Questionnaire at screening (n = 437)
| Relative importance | |||
|---|---|---|---|
| Items | Very important | Important | Not so important |
| Degree of headache pain relief, n (%) | 416 (95.2) | 18 (4.1) | 3 (0.7) |
| Time of pain relief, n (%) | 388 (88.8) | 47 (10.8) | 2 (0.5) |
| Duration of relief, n (%) | 366 (83.8) | 68 (15.6) | 3 (0.7) |
| Time to return to usual activities, n (%) | 349 (79.9) | 85 (19.5) | 3 (0.7) |
| Relief of migraine-associated symptoms, n (%) | 317 (72.5) | 111 (25.4) | 9 (2.1) |
| Efficacy of migraine treatment outweighs side effects, n (%) | 263 (60.2) | 153 (35.0) | 21 (4.8) |